维普中文期刊产品整合服务
202篇 您的检索式:作者名="MOLINA JM"
    题名 作者 年代 出处 被引量
1Gastric cancer in young people under 30 years of age: worse prognosis, or delay in diagnosis?显示文摘Horacio N López-Basave Diaz Romero C Alejandro Padilla Rosciano Melchor Ruan J Silvio A. ?amendys-Silva Vela Sarmiento I Ruiz Molina JM Calderillo Ruiz G Flavia Morales-Vásquez Abelardo Meneses Garcia Angel Herrera-Gomez 2013Cancer Management and Research (default)2013,,:2
2Tumor markers (CEA, CA125, CyFRA21-1, SCC and NSE) in patients with non-small cell lung cancer as aid in histoligical diangnosis and prognosis:comparison with the main clinical and pathological prognostic factors 显示文摘Molina R Filella X Auge JM 2003Tumor Biol2003,24,4:1
3Effect of folic acid supplementation on homocysteine concentration and association with training in handball players显示文摘MOLINA-LOPEZ J MOLINA JM CHIROSA L J 2013J Int Soc Sports Nutr2013,10,1:1
4HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases 显示文摘MOLINA R ESCUDERO JM AUGI~ JM 2011Tumor Biol2011,32,6:1
5Pro-gastrin-releasing peptide in patients with benign and malignant diseases显示文摘Molina R Auge JM Alicarte J 2004Tumour Biol2004,25,12:1
6The MTA at 8 years: Prospective follow-up of children treated for combined- type ADHD in a multisite study显示文摘Molina BS Hinshaw SP Swanson JM 2009J Am Aead Child Adolesc Psychiatry2009,48,5:1
7Sofosbuvir plus riba- virin for treatment of hepatitis C virus in patients co-in- fected with HIV (PHOTON-2) : a multicentre, open-label, non-randomised, phase 3 study显示文摘Molina JM Orkin C Iser DM 2015Lancet2015,385,9973:1
8The TNF system activity is associated with insulin resistance and dyslipidemia in my-otonic dystrophy显示文摘Fernandez-Real JM Molina A Broch M 1999Diabetes1999,48,5:1
9Ureteral endometriosis显示文摘Molina VF Serrano Bartolome JM Minguez GE 2000Arch Esp Urol2000,53,5:1
10Usefulness of serum tumor markers, including progastrin-releasing peptide, in patients with lung cancer: correlation with histology显示文摘Molina R Aug6 JM Bosch X 2009Tumour Biol2009,30,3:1
11CA125,CA199,CA153 and TAG723 as tumor markers in patients with lung cancer: comparison with CYFRA-211,CEA,SCCAg and N SE显示文摘Molina R Auge JM Escudero JM et aI 2008Tumor Biol2008,29,6:1
12Onee-dai- ly atazanavir/ritonavir compared with twice-daily lopinavir/ ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-l-infected patients: 96-week efficacy and safety results of the CASTLE study显示文摘Molina JM Andrade-Villanueva J Echevarria J 2010J Acquir Immune Defic Syndr2010,53,3:1
13Efficacy and safety of rilpivi- rine (TMC278) versus efavirenz at 48 weeks in treatment-naive HIV-l-infected patients: pooled results from the phase 3 double- blind randomized ECHO and THRIVE Trials显示文摘Cohen CJ Molina JM Cahn P et d 2012J Acquir Immune Defic Syndr2012,60,1:1
14Pro-gastrin-releasing peptide (proGRP)in patients with benign and malignant diseases:comparison with CEA,SCC,CYFRA21-1 and NSE in patients with lung cancer显示文摘Molina R Auge JM Filella X 2005Anticancer Research2005,25,3:1
15Results of laparoscopic cholecystectomy in a third-level university hospital after 17 years of experience显示文摘Priego P Ramiro C Molina JM 2009Rev Esp Enferm Dig2009,101,1:1
16HE4 a novel tnmour marker for ovarian cancer : comparison with CA 125 and ROMA algorithm in patients with gynaecologieal diseases 显示文摘Molina R Eseudero JM Aug6 JM 2011Tumour Biol2011,32,6:1
17Pro-gastrin-releasing peptide (proGRP) in patients with benign and malignant diseases: compari- son with CEA, SCC, CYFRA 21-1 and NSE in patients with lung cancer 显示文摘Molina R Auge JM Filella X 2005Antieancer Res2005,25,3:1
18HE4 a novel tumour marker for ovarian cancer: comparison with CA125 and ROMA algorithm in patients with gynaecological diseases显示文摘Molina R Escudero JM Aug6 JM 2011Tumour Biol2011,32,6:1
19Usefulness of Serum Tumor Markers, Including Progastrin-Releasing Peptide, in Patients with Lung Cancer : Correlation with Histology显示文摘Molina R Auge JM Bosch X 2009Tumor Biol2009,30,3:1
20Diagnostic relevance of circulating biomarkers in patients with lung cancer显示文摘Molina R Holdenrieder S Auge JM 2010Cancer Biomark2010,6,34:1
返回顶部 每页显示:
共11页 首页 上一页 第1页 下一页 末页 /11 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费